PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ AGONIST ATTENUATES ALCOHOL-INDUCED HEPATIC INSULIN RESISTANCE AND IMPROVES LIVER INJURY AND REPAIR

被引：0
|
作者：
Pang, Maoyin [1 ,2 ]
de la Monte, Suzanne [1 ,3 ]
He, Jiman [1 ,2 ]
Chaudhry, Rajeeve [1 ,2 ]
Duan, Kevin [1 ,2 ]
Ouh, Jiyun [1 ,2 ]
Wands, Jack R. [1 ,2 ]
机构：
[1] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Rhode Isl Hosp, Dept Med, Liver Res Ctr, Providence, RI 02903 USA
[3] Rhode Isl Hosp, Dept Pathol & Med, Providence, RI USA
来源：
HEPATOLOGY | 2008年 / 48卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
335
引用
收藏
页码：460A / 460A
页数：1
相关论文
共 50 条
  • [31] Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair
    Cai, Wei
    Yang, Tuo
    Liu, Huan
    Han, Lijuan
    Zhang, Kai
    Hu, Xiaoming
    Zhang, Xuejing
    Yin, Ke-Jie
    Gao, Yanqin
    Bennett, Michael V. L.
    Leak, Rehana K.
    Chen, Jun
    PROGRESS IN NEUROBIOLOGY, 2018, 163 : 27 - 58
  • [32] Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor α agonist
    Chen, Xiaoli
    Matthews, Jay
    Zhou, Lubing
    Pelton, Patricia
    Liang, Yin
    Xu, Jun
    Yang, Maria
    Cryan, Ellen
    Rybczynski, Philip
    Demarest, Keith
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (11): : 1516 - 1525
  • [33] Fenofibrate, a Peroxisome Proliferator-Activated Receptor α Agonist, Improves Hepatic Microcirculatory Patency and Oxygen Availability in a High-Fat-Diet-Induced Fatty Liver in Mice
    Kondo, Kazunari
    Sugioka, Tadao
    Tsukada, Kosuke
    Aizawa, Michiyoshi
    Takizawa, Masayuki
    Shimizu, Kenji
    Morimoto, Masaya
    Suematsu, Makoto
    Goda, Nobuhito
    OXYGEN TRANSPORT TO TISSUE XXXI, 2010, 662 : 77 - 82
  • [34] A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor γ with Excellent Effect on Insulin Resistance and Type 2 Diabetes
    Liu, Hui-juan
    Zhang, Cheng-yu
    Song, Fei
    Xiao, Ting
    Meng, Jing
    Zhang, Qiang
    Liang, Cai-li
    Li, Shan
    Wang, Jing
    Zhang, Bo
    Liu, Yan-rong
    Sun, Tao
    Zhou, Hong-gang
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2015, 353 (03): : 573 - 581
  • [35] Effect of aging on the expression of peroxisome proliferator-activated receptor γ and the relation to the insulin resistance
    Ye, P
    Zhang, X
    Wang, Z
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 218 - 218
  • [36] A novel peroxisome proliferator-activated receptor α/γ dual agonist ameliorates dyslipidemia and insulin resistance in prediabetic rhesus monkeys
    Ding, Shi-Ying
    Tigno, Xenia T.
    Braileanu, Gheorghe T.
    Ito, Katsuhiko
    Hansen, Barbara C.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (10): : 1334 - 1339
  • [37] Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance
    Guo, Liang
    Tabrizchi, Reza
    PHARMACOLOGY & THERAPEUTICS, 2006, 111 (01) : 145 - 173
  • [38] Partial peroxisome proliferator-activated receptor agonist angiotensin receptor blockers
    Towfighi, Amytis
    Ovbiagele, Bruce
    CEREBROVASCULAR DISEASES, 2008, 26 (02) : 106 - 112
  • [39] Lichen Planopilaris Treated With a Peroxisome Proliferator-Activated Receptor γ Agonist
    Mirmirani, Paradi
    Karnik, Pratima
    ARCHIVES OF DERMATOLOGY, 2009, 145 (12) : 1363 - 1366
  • [40] Peroxisome proliferator-activated receptor-δ attenuates colon carcinogenesis
    Harman, FS
    Nicol, CJ
    Marin, HE
    Ward, JM
    Gonzalez, FJ
    Peters, JM
    NATURE MEDICINE, 2004, 10 (05) : 481 - 483
12345